Group 1 - The core viewpoint of the article highlights that the stock price of Giant Bio (02367) has dropped over 3%, reaching a new low of 35.54 HKD, which is a significant decline from its peak in May [1] - The stock price has halved since its high point in May, indicating a severe downturn influenced by public opinion regarding collagen ingredients [1] - As of the report, the stock is down 3.46%, trading at 35.68 HKD with a transaction volume of 199 million HKD [1] Group 2 - According to Qingyan Intelligence, domestic brands secured 5 spots in the top 10 of the Douyin beauty list for this year's Double Eleven, while Giant Bio's brand, Kefu Mei, has fallen out of the top 10 [1] - On the Tmall beauty list for Double Eleven, Kefu Mei ranked 18th, a drop of 5 places compared to last year [1] - Reports indicate that Kefu Mei has consistently fallen out of the top 20 on the Douyin beauty list since June of this year [1] Group 3 - Jianghai Securities suggests that the increasing number of players in the collagen industry warrants attention on Giant Bio's future marketing strategies and sales performance for their products [1]
巨子生物跌超3%刷新年内新低 股价较5月高点已腰斩 可复美双十一排名下滑